It was demonstrated that oral administration of Bifidobacterium species including B. breve and B. longum resulted in an improved tumor control without additional treatments, and that the improvement was further augmented in combination with anti-PD-L1 antibody treatment. The gene discussed is CD274; the disease is neoplasm.